Menu

1 / 2

Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·6 months ago
#IXAnLudY
#source#chevron#alpha#research#call
Reading 0:00
15s threshold

Q1: 2026-05-07 Earnings Summary

EPS of -$3.20 beats by $0.48

|

Revenue of

$0.00

beats by $0.00

Praxis Precision Medicines, Inc. ( PRAX ) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT

Company Participants

Marcio Souza - President, CEO & Director

Tim Kelly - CFO & Treasurer

Conference Call Participants

Daniel Ferry - Lifesci Advisors, LLC

Yasmeen Rahimi - Piper Sandler & Co., Research Division

Ritu Baral - TD Cowen, Research Division

Tiago Fauth - Raymond James & Associates, Inc., Research Division

François Brisebois - LifeSci Capital, LLC, Research Division

Yatin Suneja - Guggenheim Securities, LLC, Research Division

Kambiz Yazdi - BTIG, LLC, Research Division

Lin Tsai - Jefferies LLC, Research Division

David Hoang - Deutsche Bank AG, Research Division

Jay Olson - Oppenheimer & Co. Inc., Research Division

Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division

Brian Skorney - Robert W. Baird & Co.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.